Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Tennstedt

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Cancers|October 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.
The Prostate|October 7, 2014
Tumor volume in insignificant prostate cancer: increasing threshold gains increasing riskJonas Schiffmann, Judith Connan, Georg Salomon, et al.
World Journal of Urology|October 21, 2015
Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomyKatharina Boehm, Pierre Tennstedt, Burkhard Beyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2010
Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletionEckart Laack, Ronald Simon, Marc Regier, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 27, 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancerAnna Flammiger, Florian Bayer, Ana Cirugeda-Kühnert, et al.
Experimental and Therapeutic Medicine|December 20, 2012
High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancerFrank Jacobsen, Sharad Nouraie Ashtiani, Pierre Tennstedt, et al.
European Urology|January 14, 2014
A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomyBurkhard Beyer, Thorsten Schlomm, Pierre Tennstedt, et al.
Scientific Reports|February 26, 2020
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate CancerJan K Hennigs, Sarah Minner, Pierre Tennstedt, et al.
International Journal of Oncology|September 30, 2011
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkersPierre Tennstedt, Patricia Köster, Andreas Brüchmann, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Cancers|October 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.
The Prostate|October 7, 2014
Tumor volume in insignificant prostate cancer: increasing threshold gains increasing riskJonas Schiffmann, Judith Connan, Georg Salomon, et al.
World Journal of Urology|October 21, 2015
Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomyKatharina Boehm, Pierre Tennstedt, Burkhard Beyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2010
Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletionEckart Laack, Ronald Simon, Marc Regier, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 27, 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancerAnna Flammiger, Florian Bayer, Ana Cirugeda-Kühnert, et al.
Experimental and Therapeutic Medicine|December 20, 2012
High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancerFrank Jacobsen, Sharad Nouraie Ashtiani, Pierre Tennstedt, et al.
European Urology|January 14, 2014
A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomyBurkhard Beyer, Thorsten Schlomm, Pierre Tennstedt, et al.
Scientific Reports|February 26, 2020
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate CancerJan K Hennigs, Sarah Minner, Pierre Tennstedt, et al.
International Journal of Oncology|September 30, 2011
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkersPierre Tennstedt, Patricia Köster, Andreas Brüchmann, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Pageof 12